ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,963Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 2680

$2.16M Total Retail Price of All Prescriptions

Rank: 4 out of 2680

384 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 19,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$94 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

60 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 717 621 1 15
NEXIUM 694 600 2 19
SIMVASTATIN 642 558 3 1
OMEPRAZOLE 556 452 4 2
METOPROLOL SUCCINATE 529 494 5 11
LOVAZA 479 391 6 47
AMLODIPINE BESYLATE 455 398 7 3
ATORVASTATIN CALCIUM 432 361 8 10
LEVOTHYROXINE SODIUM 425 377 9 4
FUROSEMIDE 389 346 10 7
DIOVAN 337 280 11 26
PROAIR HFA 326 249 12 52
BYSTOLIC 313 271 13 104
LOSARTAN POTASSIUM 294 263 14 18
ZOLPIDEM TARTRATE 280 216 15 17
LISINOPRIL 270 200 16 5
METFORMIN HCL ER 260 219 17 53
ALENDRONATE SODIUM 256 219 18 20
POLYETHYLENE GLYCOL 3350 248 213 19 55
RANEXA 247 221 20 173
DIOVAN HCT 243 228 21 54
AMMONIUM LACTATE 238 184 22 118
CARVEDILOL 238 191 22 27
JANUVIA 238 200 22 34
TAMSULOSIN HCL 237 205 25 25
SINGULAIR 231 200 26 64
EXFORGE 228 176 27 139
NAMENDA 223 223 28 43
SPIRIVA 216 186 29 36
SYMBICORT 214 194 30 114
CLOTRIMAZOLE-BETAMETHASONE 211 201 31 109
VENTOLIN HFA 210 175 32 61
CLOPIDOGREL 206 169 33 30
GLIPIZIDE XL 197 161 34 87
METOPROLOL TARTRATE 195 172 35 8
HYDROCHLOROTHIAZIDE 194 149 36 9
GLIPIZIDE ER 189 181 37 116
ZETIA 181 135 38 69
MECLIZINE HCL 181 153 38 105
LIDODERM 176 137 40 74
LOSARTAN-HYDROCHLOROTHIAZIDE 168 146 41 46
JANUMET 162 116 42 83
VOLTAREN 160 146 43 103
CIPROFLOXACIN HCL 152 128 44 85
PLAVIX 151 133 45 41
NIFEDIPINE ER 149 111 46 73
DEXILANT 148 142 47 133
METOCLOPRAMIDE HCL 143 100 48 150
AMITIZA 132 107 49 190
HALOBETASOL PROPIONATE 130 104 50 435
MONTELUKAST SODIUM 129 112 51 134
BENICAR 126 99 52 122
PATADAY 123 100 53 261
CYMBALTA 123 83 53 56
BENICAR HCT 121 111 55 125
HYDROCODONE-ACETAMINOPHEN 118 78 S3 56 13
AZOR 118 118 56 188
METFORMIN HCL 118 108 56 6
DICLOFENAC SODIUM 118 104 56 147
DONEPEZIL HCL 114 113 60 28
LANTUS SOLOSTAR 107 81 61 68
COREG CR 107 99 61 292
WARFARIN SODIUM 106 89 63 12
SOLARAZE 102 83 64 172
AZITHROMYCIN 102 85 64 40
EXELON 100 89 66 162
ISOSORBIDE MONONITRATE ER 98 94 67 57
CYCLOBENZAPRINE HCL 94 50 R 68 95
NOVOLOG FLEXPEN 93 83 69 194
FLUTICASONE PROPIONATE 93 72 69 38
LANSOPRAZOLE 92 73 71 121
LEVOFLOXACIN 91 65 72 108
HYDRALAZINE HCL 89 79 73 99
LIPITOR 89 77 73 78
PRAVASTATIN SODIUM 88 72 75 16
POTASSIUM CHLORIDE 87 75 76 29
GLIPIZIDE-METFORMIN 84 28 77 383
TRAMADOL HCL 84 70 77 33
DALIRESP 81 69 79 352
MEGACE ES 80 80 R 80 421
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 64 81 31
GLYBURIDE-METFORMIN HCL 75 60 R 82 96
VERAPAMIL ER 75 57 82 126
ONGLYZA 75 75 82 179
VESICARE 75 72 82 214
VIIBRYD 74 54 86 378
SERTRALINE HCL 74 66 86 23
WELCHOL 74 65 86 222
AMOX TR-POTASSIUM CLAVULANATE 73 53 89 145
GABAPENTIN 71 49 90 21
PRAMIPEXOLE DIHYDROCHLORIDE 68 56 91 329
RANITIDINE HCL 67 59 92 35
CEFUROXIME 67 55 92 241
PANTOPRAZOLE SODIUM 67 48 92 44
OXYCODONE-ACETAMINOPHEN 66 47 S2 95 106
RISPERIDONE 66 52 95 67
QVAR 64 46 97 331
TRILIPIX 61 50 98 151
MICARDIS HCT 61 41 98 205
ADVAIR DISKUS 60 54 100 32
PROPRANOLOL HCL 60 26 100 158
EFFIENT 60 36 100 371
ENDOCET 58 43 S2 103 180
UNIFINE PENTIPS 58 54 103 266
ACTOS 55 52 105 98
ADVAIR HFA 55 45 105 282
LEVEMIR FLEXPEN 54 47 107 170
IBANDRONATE SODIUM 53 50 108 223
PRISTIQ ER 53 44 108 343
GLIMEPIRIDE 53 36 108 51
OXYBUTYNIN CHLORIDE ER 51 49 111 135
DIGOXIN 51 51 111 59
AMLODIPINE BESYLATE-BENAZEPRIL 51 36 111 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.